| This article was first published on les Nouvelles, March 2026 edition. In the high-stakes biotechnology and pharmaceutical industries, and in their emerging offshoots like the fast-growing psychedelics space, patents are both a cornerstone of innovation and a potential latent source of risk. At the heart of this dynamic lie prior art and freedom-to-operate […]
Research
A Trip Through the Psychedelic IP Landscape
Over the past decade, the psychedelics industry has been undergoing a second renaissance, evolving from a niche and legally questionable research area into a burgeoning field that promises to redefine mental health and wellness. As more companies, academic institutions, and non-profits explore the therapeutic potential of compounds like psilocybin, MDMA, and LSD, the role of […]
Intellectual Property as a Non-Correlated Investment
Over the last year, market-wide uncertainty has swelled to levels not seen for over a decade. Market fluctuations now have investors increasingly searching for non-correlated returns across all asset classes in an effort to diversify away the risk brought on by this volatile market. Should investors turn to precious metals? Real estate? Emerging markets? There […]